Your browser doesn't support javascript.
loading
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression.
Ratliff, Miriam; Karimian-Jazi, Kianush; Hoffmann, Dirk C; Rauschenbach, Laurèl; Simon, Matthias; Hai, Ling; Mandelbaum, Henriette; Schubert, Marc C; Kessler, Tobias; Uhlig, Stefanie; Dominguez Azorin, Daniel; Jung, Erik; Osswald, Matthias; Solecki, Gergely; Maros, Máté E; Venkataramani, Varun; Glas, Martin; Etminan, Nima; Scheffler, Björn; Wick, Wolfgang; Winkler, Frank.
Afiliação
  • Ratliff M; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Karimian-Jazi K; Department of Neurosurgery, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.
  • Hoffmann DC; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rauschenbach L; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Simon M; Neurology Clinic and Neurooncology Program and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Hai L; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Mandelbaum H; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.
  • Schubert MC; Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty and University Hospital Bonn, Bonn, Germany.
  • Kessler T; Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany.
  • Uhlig S; Department of Neurosurgery, University of Bonn Medical Center, Bonn, Germany.
  • Dominguez Azorin D; Department of Neurosurgery, Bethel Clinic, University of Bielefeld Medical Center, OWL, Bielefeld, Germany.
  • Jung E; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Osswald M; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Solecki G; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Maros ME; Neurology Clinic and Neurooncology Program and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Venkataramani V; Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.
  • Glas M; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Etminan N; Neurology Clinic and Neurooncology Program and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
  • Scheffler B; FlowCore Mannheim and Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Wick W; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Winkler F; Neurology Clinic and Neurooncology Program and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
Neuro Oncol ; 25(12): 2150-2162, 2023 12 08.
Article em En | MEDLINE | ID: mdl-37335907
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article